Adicet Bio, Inc. (Nasdaq: ACET) is a clinical-stage biotechnology company discovering and developing a broad pipeline of allogeneic gamma delta T cell therapies, engineered with chimeric antigen receptors (CARs), alongside differentiated in vivo CAR-T therapies with the potential to redefine treatment across autoimmune diseases, hematologic malignancies and solid tumors. For more information, please visit our website at https://www.adicetbio.com. Your safety as a job seeker matters to us. Please be cautious of fraudulent recruitment activity claiming to represent Adicet. All approved positions are accessible via the Adicet Careers page at https://www.adicetbio.com/careers/openings/
- Founded
- 2014
- Company size
- 51-200
- Headquarters
- Redwood City, California, US
- Funding
- Post Ipo Equity
Hiring activity
- Open roles
- 1
- Posted in the last 30 days
- 1
Updated 6h ago
What Adicet Bio says about its culture
What Adicet Bio says it offers, drawn from its own website.
Check if you fitOpens the career fit test.
Adicet’s Mission is to Deliver Best-in-Class Gamma Delta T Cell Therapies for Patients Fighting Autoimmune Diseases & Cancer
Collaborate
“Together, we Collaborate to Innovate Courageously to develop new therapies that have curative potential for patients.”Source
Innovate Courageously
“Together, we Collaborate to Innovate Courageously to develop new therapies that have curative potential for patients.”Source
Empower
“We Empower our teams to exercise Excellence while Appreciating each other as we Develop our teams and these new therapies for patients.”Source
Excellence
“We Empower our teams to exercise Excellence while Appreciating each other as we Develop our teams and these new therapies for patients.”Source
Quoted from Adicet Bio's own website. TeaKo does not verify these claims.
Latest openings
1 open role at Adicet Bio. Members see each one.
